Advertisement
Catch up with our latest volumes and outcomes data
Below we share recent volumes and clinical outcomes from a sampling of areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation and two unique populations — patients with hypertrophic obstructive cardiomyopathy and patients with pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2022):
Of 103 rated participants in this STS category, Cleveland Clinic was 1 of 15 that achieved a 3-star (highest) rating.
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
How nurses are using frontline research to improve patient outcomes and healthcare delivery
Largest study to date confirms mortality rates similar to DBD transplant and reveals risk factors
Patient receives liver transplant and a new lease on life
Launch of the tool promises to reshape quality assessment across the specialty
Proactive bone-health management may reduce morbidity and mortality
More than 30% of patients die when early dialysis is needed after surgery
Overestimation of pain can escalate treatment, but underestimation can have other unintended consequences
Study explores role of single-dose drug in fostering the mother-infant dyad